New cream could ease debilitating hand and foot blisters

NCT ID NCT07013201

Recruiting now Disease control Sponsor: LEO Pharma Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new cream called delgocitinib can reduce painful blisters and improve skin in adults with palmoplantar pustulosis, a chronic skin condition affecting the palms and soles. About 135 participants will apply the cream or a placebo twice daily for 16 weeks to see which is more effective. The main goal is to see if the active cream leads to clearer skin and fewer symptoms compared to the inactive version.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

LEO Pharma Investigation Site
RECRUITING

Mayfield Heights, Ohio, 44124, United States
LEO Pharma Investigational Site
RECRUITING

Fountain Valley, California, 92708, United States
LEO Pharma Investigational Site
RECRUITING

Douglasville, Georgia, 30135, United States
LEO Pharma Investigational Site
RECRUITING

West Bloomfield, Michigan, 48322, United States
LEO Pharma Investigational Site
RECRUITING

Elmhurst, New York, 11373, United States
LEO Pharma Investigational Site
RECRUITING

Portland, Oregon, 97201, United States
LEO Pharma Investigational Site
RECRUITING

Philadelphia, Pennsylvania, 19103, United States
LEO Pharma Investigational Site
RECRUITING

Surrey, British Columbia, V3R 6A7, Canada
LEO Pharma Investigational Site
RECRUITING

Winnipeg, Manitoba, R3M 3Z4, Canada
LEO Pharma Investigational Site
RECRUITING

Fredericton, New Brunswick, E3B 1G9, Canada
LEO Pharma Investigational Site
RECRUITING

Hamilton, Ontario, L8L 3C3, Canada
LEO Pharma Investigational Site
RECRUITING

Hamilton, Ontario, L8N 1Y2, Canada
LEO Pharma Investigational Site
RECRUITING

Markham, Ontario, L3P 1X2, Canada
LEO Pharma Investigational Site
RECRUITING

Waterloo, Ontario, N2J 1C4, Canada
LEO Pharma Investigational Site
RECRUITING

Montreal, Quebec, H2X 2V1, Canada
LEO Pharma Investigational Site
RECRUITING

Bad Bentheim, 48455, Germany
LEO Pharma Investigational Site
RECRUITING

Dresden, 01097, Germany
LEO Pharma Investigational Site
RECRUITING

Göttingen, 37075, Germany
LEO Pharma Investigational Site
RECRUITING

Kiel, 24105, Germany
LEO Pharma Investigational Site
RECRUITING

Lübeck, 23562, Germany
LEO Pharma Investigational Site
RECRUITING

Manheim, 68167, Germany
LEO Pharma Investigational Site
RECRUITING

Münster, 48149, Germany
LEO Pharma Investigational Site
RECRUITING

Osnabrück, 49074, Germany
LEO Pharma Investigational Site
RECRUITING

Witten, 58453, Germany
LEO Pharma Investigational Site
RECRUITING

Bialystok, 15-879, Poland
LEO Pharma Investigational Site
RECRUITING

Iwonicz-Zdrój, 38-440, Poland
LEO Pharma Investigational Site
RECRUITING

Lodz, 90-436, Poland
LEO Pharma Investigational Site
RECRUITING

Lublin, 20-011, Poland
LEO Pharma Investigational Site
RECRUITING

Rzeszów, 35-055, Poland
LEO Pharma Investigational Site
RECRUITING

Warsaw, 02-482, Poland
LEO Pharma Investigational Site
RECRUITING

Wroclaw, 50-556, Poland
LEO Pharma Investigational Site
RECRUITING

Wroclaw, 50-566, Poland
LEO Pharma Investigational Site
RECRUITING

Bristol, BS2 8HW, United Kingdom
LEO Pharma Investigational Site
RECRUITING

London, SE1 9RT, United Kingdom
LEO Pharma Investigational Site
RECRUITING

Newcastle upon Tyne, NE1 4LP, United Kingdom
LEO Pharma Investigational Site
RECRUITING

Stourbridge, DY8 4JB, United Kingdom

Conditions

Explore the condition pages connected to this study.

PALMOPLANTAR PUSTULOSIS